
HIV Protease
HIV Protease inhibitors are a class of antiretroviral drugs that specifically target the protease enzyme of the Human Immunodeficiency Virus (HIV). By inhibiting this enzyme, these compounds prevent the virus from processing its polyproteins into mature, functional proteins, thereby blocking the production of new infectious virions. HIV Protease inhibitors are a cornerstone of highly active antiretroviral therapy (HAART) used to manage HIV/AIDS. At CymitQuimica, we provide a variety of HIV Protease inhibitors to support your research in HIV treatment, drug resistance, and virology.
Found 447 products of "HIV Protease"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Hinnuliquinone
CAS:<p>Hinnuliquinone is an anti-HIV agent.</p>Formula:C32H30N2O4Purity:98%Color and Shape:SolidMolecular weight:506.59Delavirdine
CAS:<p>Delavirdine, an NNRTI for HIV-1, is used in HAART.</p>Formula:C22H28N6O3SColor and Shape:SolidMolecular weight:456.56HIV-1 inhibitor-80
<p>HIV-1inhibitor-80 (compound M44) is an HIV-1 inhibitor with an EC50 of 5-148 nM. It demonstrates excellent metabolic stability and low cytotoxicity in human plasma and liver microsomes.</p>Formula:C26H19N7OColor and Shape:SolidMolecular weight:445.475Hypoglaunine D
CAS:<p>Hypoglaunine D, an anti-HIV analogue of Triptonine B, inhibits HIV in H9 cells with an EC50 of 22 μg/ml.</p>Formula:C41H47NO19Color and Shape:SolidMolecular weight:857.81(2S,5S)-Censavudine
<p>(2S,5S)-Censavudine, a potent HIV inhibitor and nucleoside reverse transcriptase blocker.</p>Formula:C12H12N2O4Color and Shape:SolidMolecular weight:248.23CI-39
CAS:<p>CI-39, an NNRTI with EC50 of 3.40 µM, inhibits HIV-1 reverse transcriptase and RNase H, with CC50 >30 µM.</p>Formula:C19H18N2O4Color and Shape:SolidMolecular weight:338.36HIV-1 protease-IN-4
<p>HIV-1 protease-IN-4, a prodrug of atazanavir, delivers 5x AUC & 67x C24 compared to atazanavir.</p>Formula:C48H69N7O11Color and Shape:SolidMolecular weight:920.1Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium
CAS:<p>Tenofovir-C3-O-C12 has a longer half-life, potent anti-HIV effects, and better pharmacokinetics than tenofovir.</p>Formula:C29H55N6O5PSiColor and Shape:SolidMolecular weight:626.855VIR-165
<p>VIR-165, a derivative of VIRIP (353-372 of alpha1-antitrypsin), blocks several HIV-1 strains.</p>Formula:C109H158N22O25S2Purity:98%Color and Shape:SolidMolecular weight:2240.712-Oxocalanolide A
<p>12-Oxocalanolide A is a useful organic compound for research related to life sciences and the catalog number is T125675.</p>Formula:C22H24O5Color and Shape:SolidMolecular weight:368.429HIV-IN-2
CAS:<p>HIV-IN-2 (Compound 100) is a potent inhibitor of HIV, showing potential for research into HIV infection [1].</p>Formula:C34H27ClF7N9O3SColor and Shape:SolidMolecular weight:810.14Lopinavir Metabolite M-1
CAS:<p>Lopinavir Metabolite M-1, derived from Lopinavir, inhibits HIV protease (Ki=0.7 pM) and shows antiviral activity in vitro.</p>Formula:C37H46N4O6Color and Shape:SolidMolecular weight:642.78Tenofovir-C3-O-C15-CF3 ammonium
CAS:<p>Tenofovir-C3-O-C15-CF3 (ammonium) has a longer half-life and stronger anti-HIV action, improving pharmacokinetics in vivo.</p>Formula:C28H52F3N6O5PColor and Shape:SolidMolecular weight:640.73GLR-19
CAS:<p>GLR-19 is an anti-HIV peptide with demonstrated antiviral activity against HSV-2 [1] [2].</p>Formula:C102H194N40O20Purity:98%Color and Shape:SolidMolecular weight:2300.89NF279
CAS:<p>P2X1 antagonist</p>Formula:C49H36N6Na6O23S6Purity:98%Color and Shape:SolidMolecular weight:1407.17CTP518
CAS:<p>CTP518, a deuterated Atazanivir derivative, is a HIV protease inhibitor.</p>Formula:C38H52N6O7Purity:98%Color and Shape:SolidMolecular weight:719.95Carbovir triphosphate
CAS:<p>Carbovir triphosphate (CBV-TP), a phosphorylated metabolite, serves as a research tool for studying human immunodeficiency virus (HIV) [1].</p>Formula:C11H16N5O11P3Color and Shape:SolidMolecular weight:487.19Indoline
CAS:<p>Compound PDK0239, with CAS No. 496-15-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0239 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.</p>Formula:C8H9NColor and Shape:Clear To Yellow LiquidMolecular weight:119.16(+)-Carbovir triphosphate
CAS:<p>(+)-Carbovir triphosphate, Abacavir's active metabolite, studied for HIV-1 resistance and inhibition mechanisms.</p>Formula:C11H16N5O11P3Color and Shape:SolidMolecular weight:487.19HIV p17 Gag (77-85)
CAS:<p>Targeting HIV Gag p17 (77-85) with intracellular Ab cDNA disrupts viral replication pre/post-integration.</p>Formula:C44H72N10O15Purity:98%Color and Shape:SolidMolecular weight:981.1

